Detalles de la búsqueda
1.
Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia.
Blood;
138(7): 571-583, 2021 08 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33889952
2.
IDEAL study: A real-world assessment of pattern of use and clinical outcomes with recombinant coagulation factor IX albumin fusion protein (rIX-FP) in patients with haemophilia B in Italy.
Haemophilia;
29(1): 135-144, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36423202
3.
Use of the von Willebrand factor concentrate with low factor VIII content to manage patients with inherited von Willebrand disease requiring surgical or secondary long-term prophylaxis: An expert opinion paper from an Italian panel.
Eur J Haematol;
109(2): 121-128, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35531770
4.
Italian experience with rVIII-single chain: a survey of patients with haemophilia A and their physicians.
J Thromb Thrombolysis;
53(4): 934-944, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-34775566
5.
Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study.
Blood;
134(20): 1708-1711, 2019 11 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31570488
6.
Immune tolerance induction with moroctocog-alpha (Refacto/Refacto AF) in a population of Italian haemophilia A patients with high-titre inhibitors: Data from REF.IT Registry.
Haemophilia;
25(6): 1003-1010, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31603594
7.
Thrombopoietin receptor agonists in patients with persistent or chronic immune thrombocytopenia.
Eur J Haematol;
100(3): 304-307, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29243329
8.
Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease.
Am J Hematol;
91(10): 995-1001, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27351715
9.
Pharmacokinetics of a new human plasma-derived double virus inactivated and nanofiltered factor IX concentrate in previously treated severe or moderately severe haemophilia B patients.
Haemophilia;
25(6): e364-e367, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31509326
10.
Anti-ADAMTS13 Autoantibodies: From Pathophysiology to Prognostic Impact-A Review for Clinicians.
J Clin Med;
12(17)2023 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37685697
11.
Surgery and Prophylaxis with Susoctocog-Alfa in Acquired Hemophilia: Case Series and Literature Review.
J Clin Med;
12(14)2023 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37510704
12.
Pediatric immune thrombocytopenia: a focus on eltrombopag as second-line therapy.
Hematology;
28(1): 2210906, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37199369
13.
Management of patients with bleeding disorders and educational needs regarding hemophilia a in 23 italian emergency departments - Results from a survey conducted in Piedmont.
Acta Biomed;
93(5): e2022293, 2022 10 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36300218
14.
Analytical Performance of Different Laboratory Methods for Measuring Susoctocog-Alfa.
Diagnostics (Basel);
12(8)2022 Aug 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36010349
15.
Current Choices and Management of Treatment in Persons with Severe Hemophilia A without Inhibitors: A Mini-Delphi Consensus.
J Clin Med;
11(3)2022 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35160253
16.
ADAMTS13 Autoantibodies and Burden of Care in Immune Thrombotic Thrombocytopenic purpura: New Evidence and Future Implications.
Clin Appl Thromb Hemost;
28: 10760296221125785, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36124377
17.
Impact of COVID-19 Infection, Vaccination, and Serological Response in Immune Thrombocytopenic Purpura Patients: A Single-Center Global Analysis.
Biomedicines;
10(11)2022 Oct 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36359194
18.
Intracranial Haemorrhage in Haemophilia Patients Is Still an Open Issue: The Final Results of the Italian EMO.REC Registry.
J Clin Med;
11(7)2022 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35407576
19.
Simulation of the Impact on the Workload of the Enlargement of the Clinical Staff of a Specialistic Reference Center.
Stud Health Technol Inform;
281: 605-609, 2021 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34042647
20.
Second-line administration of thrombopoietin receptor agonists in immune thrombocytopenia: Italian Delphi-based consensus recommendations.
Ther Adv Hematol;
12: 20406207211048361, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34646432